BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – BIOA

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=128036&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Class Action Filed Against Crocs, Inc. (CROX) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128035&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Notice of Data Breach

ATHENS, OHIO / ACCESS Newswire / February 7, 2025 / Athens County Board of Developmental Disabilities What Happened On May 28, 2024, Athens County Board of Developmental Disabilities (ACBDD) became aware of technical issues related to our server. Upon discovery, we took immediate action to investigate the incident and secure our systems. We retained outside

PriceSmart Announces 8.6% Increase to Annual Dividend and; Voting Results from the 2025 Annual Meeting of Stockholders

PriceSmart, Inc. (“PriceSmart” or the “Company”) (NASDAQ: PSMT), operator of 54 warehouse clubs in 12 countries and one U.S. territory, today announced an 8.6% increase to its annual dividend and the results of the Company's 2025 annual meeting of stockholders that was held on February 6, 2025. https://mma.prnewswire.com/media/1740875/PriceSmart_Inc_Logo.jpg Declaration of Cash Dividend OnFebruary 6, 2025,

AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

Amgen (NASDAQ: AMGN) will present at the 35th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m. ET on Wednesday, Feb. 12, 2025. Narimon Honarpour, senior vice president of global development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:REPL), WOBURN, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees. The Company granted equity awards to 34 employees as a material inducement to commencing their employment

Gaia Announces Closing of Underwritten Offering of $8.0 Million of Common Stock

(NasdaqGM:GAIA), BOULDER, Colo., Feb. 07, 2025 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA) (“Gaia” or the “Company”), a conscious media and community company, announced today the closing of its previously announced underwritten public offering of 1,600,000 shares of its Class A common stock at a price to the public of $5.00 per share. Net proceeds

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:NAMS),(NasdaqGM:NAMSW), NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or

Mynaric Secures Another USD 28 Million Bridge Loan, Extends Three Outstanding Bridge Loans, Agrees to USD 25 Million Restructuring Loan and Resolves on Reorganization Under StaRUG

MUNICH, DE / ACCESSWIRE / February 7, 2025 / Mynaric AG (NASDAQ:MYNA) (ISIN: US62857X1019) (FRA:M0YN) (ISIN: DE000A31C305) (the "Company") announces the grant of a fourth bridge loan, the extension of the maturity date of its three outstanding bridge loans, agrees to a new restructuring loan and resolves on a financial restructuring by proceedings under the

Blue Diamond Growers Supports Agriculture Export Promotion Act of 2025

Blue Diamond Growers, the largest almond processor and marketer, issued a statement of support following the reintroduction of the Agriculture Export Promotion Act of 2025. https://mma.prnewswire.com/media/159190/blue_diamond_growers_logo.jpg The Company issued the following statement:”Blue Diamond applauds U.S. Representatives Dan Newhouse (R-WA-04), Tracey Mann (R-KS-01), Jim Costa (D-CA-21), Jimmy Panetta (D-CA-19), Ashley Hinson (R-IA-02), Brad Finstad (R-MN-01), Chellie

Scroll to Top